)
)
Atea Pharmaceuticals Investor Relations Material
Latest events
Q3 2024
Atea Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Atea Pharmaceuticals Inc
Access all reports
Atea Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing antiviral therapies for the treatment of viral diseases. The company's research and development efforts primarily target diseases such as hepatitis C, dengue, and COVID-19. Atea leverages its expertise in nucleoside and nucleotide therapeutics to create treatments aimed at addressing unmet medical needs in the antiviral space. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Atea Pharmaceuticals Inc
Q2 2024
Atea Pharmaceuticals Inc
Q4 2023
Atea Pharmaceuticals Inc
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
AVIR
Country
🇺🇸 United States